PETRONE, DANIELE
 Distribuzione geografica
Continente #
EU - Europa 222
NA - Nord America 70
AS - Asia 22
SA - Sud America 1
Totale 315
Nazione #
IT - Italia 197
US - Stati Uniti d'America 69
SG - Singapore 21
BG - Bulgaria 9
FI - Finlandia 6
DE - Germania 4
FR - Francia 2
GB - Regno Unito 2
BR - Brasile 1
ES - Italia 1
IE - Irlanda 1
IN - India 1
MX - Messico 1
Totale 315
Città #
Rome 125
Milan 24
New York 18
Ashburn 9
Sofia 9
Helsinki 4
Bologna 3
Lodi 3
Singapore 3
Alghero 2
Campobasso 2
Castelvetro Piacentino 2
Colorno 2
Frankfurt am Main 2
Genoa 2
Lappeenranta 2
Naples 2
Oxford 2
Paris 2
Reggio Emilia 2
Armunia 1
Boardman 1
Brookline 1
Dublin 1
Hamburg 1
Mattinata 1
Mexico City 1
Molfetta 1
Pisa 1
Pontenure 1
Pune 1
Seattle 1
São Paulo 1
Turin 1
Urbino 1
Totale 235
Nome #
Early warning systems for emerging profiles of antimicrobial resistance in Italy. A national survey 49
Meningiti, meningo-encefaliti ed encefaliti da virus Toscana in Italia, 2016-2021. Punta dell’iceberg di una arbovirosi endemica poco conosciuta 29
Assessing COVID-19-Related Excess Mortality Using Multiple Approaches—Italy, 2020–2021 24
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy. A retrospective matched cohort study 23
The impact of rotavirus vaccination on discharges for pediatric gastroenteritis in Italy. An eleven year (2009–2019) nationwide analysis 22
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022) 21
Il sistema di sorveglianza basato su eventi in Italia dal 2009 al 2021. Verso una intelligence di sanità pubblica 18
Unveiling the incidences and trends of the neglected zoonosis cystic echinococcosis in Europe: a systematic review from the MEmE project 14
Focolaio di COVID-19 in un campo estivo nella Regione Piemonte (2021): descrizione, lezioni apprese e raccomandazioni per futuri campi estivi 14
Relative effectiveness of monovalent and bivalent mrna boosters in preventing severe covid-19 due to omicron ba.5 infection up to 4 months post-administration in people aged 60 years or older in Italy. A retrospective matched cohort study 13
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021 13
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy. A retrospective analysis of January-April, 2022 13
Estimated effectiveness of a primary cycle of protein recombinant vaccine nvx-cov2373 against COVID-19 12
Differences in the incidence and clinical outcomes of SARS-CoV-2 infection between Italian and non-Italian nationals using routine data 12
Characteristics of COVID-19 cases in Italy from a sex/gender perspective 11
Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy. Update on the 28th of march 2021 11
Rapid increase in neuroinvasive west Nile virus infections in humans, Italy, July 2022 11
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023 10
Impatto della vaccinazione e della pregressa diagnosi sul rischio di infezione e di malattia severa associata a SARS-CoV-2. Un’analisi dei casi diagnosticati nel mese di ottobre 2022 10
Infezione da Sars-CoV-2 nel 2022: confronto della gravità del lignaggio BA.5 rispetto al lignaggio BA.2 10
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022 9
Winning during a pandemic: epidemiology of SARS-CoV-2 during EURO2020 in Italy 9
Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January-September 2021 9
null 8
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel 8
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 8
Impact of tiered restrictions on human activities and the epidemiology of the second wave of COVID-19 in Italy 6
Risk and protective factors for {sars}-{cov}-2 reinfections, surveillance data, Italy, August 2021 to March 2022 5
Valutazione della qualità delle notifiche di decesso associate a COVID-19 riportate al sistema di sorveglianza integrata COVID-19 ISS: confronto con la rilevazione sulle cause di morte dell’Istat - Italia, 2020 4
Socioeconomic inequalities in SARS-CoV-2 infection and COVID-19 health outcomes in urban Italy during the COVID-19 vaccine rollout, January–November 2021 4
Intelligent Natural Language Processing for Epidemic Intelligence 3
Spatial spread of COVID-19 during the early pandemic phase in Italy 3
Infezione da SARS-CoV-2: minore gravità clinica della variante Omicron rispetto alla variante Delta 2
Impatto del COVID-19 dopo l’inizio della vaccinazione in gruppi di popolazione a rischio, tra cui gli immunocompromessi: Italia 2021-2023 1
Totale 419
Categoria #
all - tutte 2.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023102 0 0 0 0 0 5 17 24 4 2 20 30
2023/2024317 11 32 25 81 26 47 4 38 13 16 24 0
Totale 419